Charles River Laboratories International (CRL) Invested Capital (2016 - 2025)
Historic Invested Capital for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.
- Charles River Laboratories International's Invested Capital fell 994.95% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 994.95%. This contributed to the annual value of $3.5 billion for FY2024, which is 375.66% down from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Invested Capital is $3.4 billion, which was down 994.95% from $3.4 billion recorded in Q2 2025.
- Charles River Laboratories International's Invested Capital's 5-year high stood at $3.8 billion during Q3 2024, with a 5-year trough of $2.2 billion in Q1 2021.
- For the 5-year period, Charles River Laboratories International's Invested Capital averaged around $3.1 billion, with its median value being $3.2 billion (2025).
- Per our database at Business Quant, Charles River Laboratories International's Invested Capital skyrocketed by 2863.99% in 2021 and then tumbled by 1223.29% in 2025.
- Charles River Laboratories International's Invested Capital (Quarter) stood at $2.5 billion in 2021, then grew by 17.28% to $3.0 billion in 2022, then increased by 20.84% to $3.6 billion in 2023, then decreased by 3.76% to $3.5 billion in 2024, then decreased by 1.63% to $3.4 billion in 2025.
- Its Invested Capital was $3.4 billion in Q3 2025, compared to $3.4 billion in Q2 2025 and $3.2 billion in Q1 2025.